Novo Nordisk Stock Today, 28 November 2025: Goldman Sachs Trims Target as Obesity Pipeline Fights Back
Novo Nordisk (NYSE: NVO) shares are trying to stabilise after a bruising November as fresh obesity‑drug data, a higher‑dose Wegovy filing and new analyst calls collide with lingering worries about growth and competition. 1. How Novo Nordisk stock is trading today Novo Nordisk’s U.S.-listed ADRs are changing hands around $49.25, up roughly 1% on the day, after trading between $48.35 and $49.75 in Friday’s session. Intraday volume…